Experimental evaluation of efficacy of a HIV filter
Received date: 2019-10-10
Online published: 2019-12-25
目的:检验某公司生产的一次性人类免疫缺陷病毒(human immunodeficiency virus, HIV)过滤器的HIV去除率。方法:使用某公司生产的一次性HIV过滤器,将含有HIV的血浆通过该过滤器加压过滤,通过检测过滤前后血浆中的HIV RNA含量,判断该HIV病毒过滤器的滤过效率。结果:本研究共纳入10份血样,一次性HIV过滤器平均去除率为96.62%,过滤前后的血浆HIV含量差异有统计学意义(P=0.001),过滤率高低与过滤前HIV含量高低间未发现线性关系(P=0.924 2)。结论:一次性HIV过滤器对HIV病毒的病毒去除率处于较高水平,结果提示采用物理吸附过滤HIV病毒的方法是较可行的。
张林, 周莹, 李海聪, 孙美艳, 孙文秀, 陆玲庆, 朱召芹, 唐琪, 张仁芳, 沈银忠, 卢洪洲 . HIV病毒过滤器过滤效率的评估实验研究[J]. 诊断学理论与实践, 2019 , 18(06) : 676 -679 . DOI: 10.16150/j.1671-2870.2019.06.014
Objective: To test the efficacy of a disposable membrane filter for the elimination of HIV. Methods: A total of 10 plasma samples were tested in this study. Plasma samples containing HIV were pressurizedly filtered through the filter. Copies of HIV RNA in the plasma before and after filtration were counted to calculate the efficacy of the filter. Results: The average HIV clearance rate of the filter was 96.62%. There was significant difference in number of HIV RNA copies before and after filtration (P=0.001). However, linear relationship was not seen between the clearance rate and the initial number of HIV RNA copies (P=0.924 2). Conclusions: The HIV clearance rate of this disposable membrane filter is high, and it might be feasible to eliminate the HIV virus by physical adsorption.
[1] | UNAIDS.Data 2019[DB].https://www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data |
[2] | 疾病预防控制局.2018年12月全国法定传染病疫情概况[EB/OL]. (2019-01-17)[2019-12-25].http://www.nhfpc.gov.cn/jkj/s3578/new_list.shtml. |
[3] | 中国疾病预防控制中心, 性病艾滋病预防控制中心, 性病控制中心. 2018年第3季度全国艾滋病性病疫情[J]. 中国艾滋病性病, 2018, 24(11):1075. |
[4] | 韩孟杰. 2018年全国HIV的疫情概况[C]// 中国疾病预防控制中心.北京, 2018. |
[5] | Neupane S, Dhungana GP, Ghimire HC. Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal[J]. BMC Public Health, 2019, 19(1):720. |
[6] | Dupont E, Yombi JC. Is antiretroviral two-drug regimen the new standard for HIV treatment in naive patients?[J]. AIDS Rev, 2019, 21(3):143-156. |
[7] | 张智远, 宁少萍. 艾滋病抗病毒治疗595例药物毒副反应分析[J]. 基层医学论坛, 2014, 18(29):4004-4005. |
[8] | Marzolini C, Back D, Weber R, et al. Ageing with HIV: medication use and risk for potential drug-drug interactions[J]. J Antimicrob Chemother, 2011, 66(9):2107-2111 |
[9] | Morowatisharifabad MA, Movahed E, Farokhzadian J, et al. Antiretroviral therapy adherence and its determinant factors among people living with HIV/AIDS: a case study in Iran[J]. BMC Res Notes, 2019, 12(1):162 |
[10] | 张晓伟, 刘志斌, 郭会军. 服药依从性对HAART的艾滋病病人血浆药物浓度及免疫功能和病毒载量的影响[J]. 中国艾滋病性病, 2016, 22(11):850-852. |
[11] | Hosseinipour MC, van Oosterhout JJ, Weigel R, et al. The public health approach to identify antiretroviral the-rapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy[J]. AIDS, 2009, 23(9):1127-1134. |
/
〈 |
|
〉 |